IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Instant Total Contact Cast to Heal Diabetic Foot Ulcers (ITCC)
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2010 by University of Texas Southwestern Medical Center.
Recruitment status was: Recruiting
Recruitment status was: Recruiting
Sponsor:
University of Texas Southwestern Medical Center
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by:
University of Texas Southwestern Medical Center
ClinicalTrials.gov Identifier:
NCT01221207
First received: October 13, 2010
Last updated: October 15, 2010
Last verified: October 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Aim 1. To compare the effectiveness of total contact casts (TCC), removable cast walkers (RCW) and instant total contact casts (ITCC) to heal diabetic foot ulcers in a 20 week randomized clinical trial of 225 patients in community care in three university medical center diabetes clinics.
Aim 2. To compare the frequency of complications such as soft tissue and bone infections, iatrogenic wounds, falls and fall related injuries, and amputations among patients treated with TCC, ITCC and RCW to heal diabetic foot ulcers.
Aim 3. To compare patient compliance and level of activity among TCC, ITCC, RCW treatment groups. Using computerized activity monitors which time-stamp each step, we will evaluate both degree and magnitude of activity between groups.
Aim 4. To evaluate the cost of diabetic foot ulcer-related treatment and complications during the course of therapy.
| Condition | Intervention |
|---|---|
| Diabetic Foot Ulcers | Device: Total Contact Cast Device: Instant Total Contact Cast (ITCC) Device: Removable Cast Walker (RCW) |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Investigator) Primary Purpose: Treatment |
| Official Title: | Instant Total Contact Cast to Heal Diabetic Foot Ulcers |
Resource links provided by NLM:
Further study details as provided by University of Texas Southwestern Medical Center:
Primary Outcome Measures:
- Wound Evaluation and Healing: The lower extremity evaluation will include length, width, depth, and area of the ulcer before and after debridement. [ Time Frame: every 10 days, then every 4 months ]We will evaluate wounds at each clinical visit to ensure the absence of infection. At each study visit a research CRC will take photographs of the wound which will be planimetrically measured and assessed by a clinician unaware of specific study allocation. An ulcer will be considered "healed" when it is fully epithelialized with no drainage.
Secondary Outcome Measures:
- Evaluation of Complications: At each visit the study nurse will interview patients and determine if they have experienced any adverse events. [ Time Frame: every 10 days, then every 4 months ]This includes exacerbation of existing condition or event. Infection of soft tissue or bone, amputation, need for incision and drainage, iatrogenic ulcer formation, deterioration of the ulcer being treated, hospital admission, surgery of the foot or amputation of the foot or leg will be considered as an adverse event.
| Estimated Enrollment: | 225 |
| Study Start Date: | October 2010 |
| Estimated Study Completion Date: | October 2012 |
| Estimated Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Device - Total Contact Cast (TCC)
A total contact cast (TCC) is a special cast technique that is used to take the pressure and shear stress off the ulcer to assist in the healing.
|
Device: Total Contact Cast
A total contact cast (TCC) is a special cast technique that is used to take the pressure and shear stress off the ulcer to assist in the healing.
|
|
Active Comparator: Removable Cast Walker (RCW)
The removable cast walker (RCW) is a commercial product that is similar to a cast. It is secured with Velcro straps around the foot and leg and it is also effective at removing the pressure and shear stress on the foot.
|
Device: Removable Cast Walker (RCW)
The removable cast walker (RCW) is a commercial product that is similar to a cast. It is secured with Velcro straps around the foot and leg and it is also effective at removing the pressure and shear stress on the foot.
|
|
Active Comparator: Instant Total Contact Cast (ITCC)
The instant total contact cast (ITCC) is a technique that uses the removable cast walker, but secures it so it cannot be removed between clinic visits and evaluation by the subject or the physician.
|
Device: Instant Total Contact Cast (ITCC)
The instant total contact cast (ITCC) is a technique that uses the removable cast walker, but secures it so it cannot be removed between clinic visits and evaluation by the subject or the physician.
|
Detailed Description:
This is an investigator blinded randomized, controlled clinical trial with three parallel treatment groups of 75 adult outpatients with diabetes mellitus and a foot ulcer. The study will be conducted at five university affiliated medical centers in Arizona and Texas. The study participants and nurse coordinator will not be blinded to the treatment after randomization. Investigators will be blinded to treatment group assignment.
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Men or women 18 years old or older
- One or more foot ulcers without clinical evidence of osteomyelitis
- Diagnosis of Diabetes Mellitus
- University of Texas Grade 1A-B, 2A-B or 3A-B
- ABI >0.5
- Spanish-speaking subjects will be eligible to participate
Exclusion Criteria:
- Active Charcot Arthropathy
- ABI <0.5
- Gangrene, active infection
- Unable to keep research appointments
- Wide spread malignancy or systemically immunocompromising disease
- Alcohol or substance abuse within 6 months
- Unreliable, unwilling or unable to comprehend informed consent
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01221207
Please refer to this study by its ClinicalTrials.gov identifier: NCT01221207
Contacts
| Contact: Lawrence Lavery, DPM | 214-645-0544 | LLAVE1@mednet.swmed.edu | |
| Contact: Cecilia Lara | 214-645-2377 | cecilia.lara@utsouthwestern.edu |
Locations
| United States, Arizona | |
| University of Arizona | Recruiting |
| Tucson, Arizona, United States | |
| Contact: David Armstrong, D 520-626-1349 | |
| United States, Texas | |
| Parkland Health & Hospital Systems | Not yet recruiting |
| Dallas, Texas, United States, 75235 | |
| Contact: Lawrence Lavery, DPM 214-645-0544 LLAVE1@mednet.swmed.edu | |
| Contact: Cecilia Lara 214-645-2377 cecilia.lara@utsouthwestern.edu | |
| UT Southwestern Medical Center at Dallas | Not yet recruiting |
| Dallas, Texas, United States, 75390 | |
| Contact: Lawrence Lavery, DPM 214-645-0544 LLAVE1@mednet.swmed.edu | |
| Contact: Cecilia Lara 214-645-2377 cecilia.lara@utsouthwestern.edu | |
| Scott & White | Recruiting |
| Temple, Texas, United States | |
| Contact: Douglas Murdoch, DPM 214-771-7604 DMurdoch@swmail.sw.org | |
Sponsors and Collaborators
University of Texas Southwestern Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Investigators
| Principal Investigator: | Lawrence Lavery, DPM | UT Southwestern Medical Center at Dallas |
More Information
| Responsible Party: | Lawrence Lavery, DPM, The University of Texas Southwestern Medical Center at Dallas |
| ClinicalTrials.gov Identifier: | NCT01221207 History of Changes |
| Other Study ID Numbers: |
UTSW - 7R01DK074483-04 |
| Study First Received: | October 13, 2010 |
| Last Updated: | October 15, 2010 |
Keywords provided by University of Texas Southwestern Medical Center:
|
diabetic foot ulcers casting wound care |
Additional relevant MeSH terms:
|
Diabetic Foot Foot Ulcer Foot Diseases Ulcer Pathologic Processes Diabetic Angiopathies Vascular Diseases Cardiovascular Diseases Leg Ulcer Skin Ulcer |
Skin Diseases Diabetes Complications Diabetes Mellitus Endocrine System Diseases Diabetic Neuropathies Calpastatin Cysteine Proteinase Inhibitors Protease Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action |
ClinicalTrials.gov processed this record on June 28, 2017